Leonard Guarente, PhD
MIT aging biologist and Elysium Chief Scientist known for foundational sirtuin and NAD+ research
At a glance
- Years in practice
- 44
- Languages
- English
Practice
About
Leonard Guarente, PhD is Elysium Health's Co-Founder and Chief Scientist and the Novartis Professor of Biology at MIT, where he directs the Paul F. Glenn Center for Biology of Aging Research. His lab is central to sirtuin and NAD+ aging biology, including work identifying SIR2 as a longevity regulator and showing that sirtuins are NAD+-dependent enzymes. He co-founded Elysium in 2014 with Eric Marcotulli and Dan Alminana, giving the company a direct link to MIT aging-biology research.
Approach
Signature approach
Guarente's role is scientific foundation. Basis connects to his lab's NAD+/sirtuin body of work, while Index follows Elysium's broader pattern of taking academic aging-biology methods into consumer products. His presence gives Elysium a direct line to MIT biology instead of a purely commercial supplement or testing posture.
What sets them apart
- Sirtuin/NAD+ lineage. Guarente's work helped define the field that made NAD+ biology central to consumer longevity.
- MIT Glenn Center role. He directs a major academic aging-biology center while serving as Elysium's Chief Scientist.
- Scientific family tree. David Sinclair, Brian K. Kennedy, and Matt Kaeberlein trained in his lab.
- Publication scale. Semantic Scholar listed roughly 332 publications, h-index 137, and about 85K citations at capture.
Focus
Specialties
Training
Education
- PhDHarvard University (1978)
- SB, BiologyMassachusetts Institute of Technology (1974)
- Years in longevity
- 34
Published work
Books
- Ageless Quest: One Scientist's Search for Genes That Prolong YouthCold Spring Harbor Laboratory Press, 2003
- Elsevier, 2018
Publications
- Nature, 2000
- Science, 2000
- Nature, 2001
- Cell, 1995
- Nature, 2004
- Genes & Development, 1999
- Nature Reviews Neuroscience, 2017
- Life Science Alliance, 2019
- iScience, 2022
Elsewhere
Media and talks
- The New York Times · 2000-09-26
- The EnthusiastMIT Technology Review · 2007-08-15
- An MIT Scientist Claims That This Pill Is the Fountain of YouthNew York Magazine · 2016
- MIT News · 2009-09-15
- The Human Upgrade
- Mind & Matter · 2022-05
- InsideTracker · 2022-08
Collaboration
- David Sinclair, PhDPostdoc in Guarente lab (1993); now Harvard Medical School aging biologist
- Brian K. Kennedy, PhDDoctoral student in Guarente lab; aging biologist (NUS, formerly Buck Institute)
- Matt Kaeberlein, PhDDoctoral student in Guarente lab; aging biologist (formerly UW; Optispan)
- Cynthia Kenyon, PhDCo-founder of Elixir Pharmaceuticals (1999) and parallel pioneer of aging genetics
Verification
- Profile updated
- Credentials checked
- Affiliations verified
Primary sourcehttps://www.elysiumhealth.com/blogs/leadership-team/leonard-guarente-phd
Where a detail is missing, it means we have not verified it—not that the answer is no. Directory listings are for informational purposes only. Inclusion does not constitute endorsement. Verify credentials and qualifications independently.